Floatz logo

Therapeutic Asset Ratings

5,099 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
N-Butyl Cyanoacrylate
Periampullary Adenocarcinoma
Minia UniversityP3B (61)
Nemtabrutinib
B-Cell Chronic Lymphocytic Leukemia
Merck Sharp & Dohme LLCP3B (61)
Nepenthe
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer CenterP3B (61)
Niraparib
BRCA2-Related Cancer Predisposition
Qian QinP3B (61)
Niraparib
Small Cell Lung Carcinoma
ETOP IBCSG Partners FoundationP3B (61)
Nivestim
Angioimmunoblastic T-Cell Lymphoma
City of Hope Medical CenterP3B (61)
Nivestim
Glioblastoma
Massachusetts General HospitalP3B (61)
Nivestim
Lung Cancer
University of WashingtonP3B (61)
Nivolumab
Cancer
ExelixisP3B (61)
Nivolumab
Metastatic Malignant Neoplasm In The Brain
Stanford UniversityP3B (61)
Nivolumab
Ovarian Carcinoma
Instituto do Cancer do Estado de São PauloP3B (61)
Nivolumab
Head And Neck Cancer
Fate TherapeuticsP3B (61)
Nivolumab
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP3B (61)
Ntla-2002
Hereditary Angioedema
Intellia TherapeuticsP3B (61)
Ocrelizumab
Secondary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.P3B (61)
Olaparib
Breast Neoplasm
Merck Sharp & Dohme LLCP3B (61)
Olaparib
Peritoneal Neoplasm
Merck Sharp & Dohme LLCP3B (61)
Olaparib
Small Cell Lung Carcinoma
University of CologneP3B (61)
Olaparib
Triple-Negative Breast Carcinoma
AHS Cancer Control AlbertaP3B (61)
Olverembatinib
Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (61)
Padeliporfin
Prostate Cancer
Steba Biotech S.A.P3B (61)
Palazestrant
Estrogen-Receptor Positive Breast Cancer
Olema Pharmaceuticals, Inc.P3B (61)
Paltusotine
Carcinoid Tumor
Crinetics Pharmaceuticals Inc.P3B (61)
Pegaspargase
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Children's Oncology GroupP3B (61)
Pegfilgrastim
Classic Hodgkin Lymphoma
Michael Spinner, MDP3B (61)
Showing 2126 to 2150 of 5,099 assets
PreviousPage 86 of 204Next